More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$3.99B
EPS
0.41
P/E ratio
63.2
Price to sales
1.51
Dividend yield
--
Beta
0.884563
Previous close
$24.06
Today's open
$24.16
Day's range
$23.81 - $24.52
52 week range
$18.25 - $30.42
show more
CEO
Paul Keel
Employees
12000
Headquarters
Brea, CA
Exchange
New York Stock Exchange
Shares outstanding
162727923
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Here's Why You Should Retain NVST Stock in Your Portfolio for Now
Envista Holdings Corporation's NVST ongoing international expansion is strengthening its presence across a broader range of markets, creating significant opportunities for long-term growth. Supported by the company's strategic priorities and growth-focused initiatives, it is well positioned to capitalize on emerging opportunities and deliver solid operational and financial performance in the upcoming quarters.
Zacks Investment Research • Jun 8, 2026

Why Is Envista (NVST) Down 5.9% Since Last Earnings Report?
Envista (NVST) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Jun 5, 2026

Is NVST Attractive at 15.1x Forward Earnings?
Envista trades at 15.1x forward earnings; Q1 2026 profit surged, and a $24 target hinges on sustaining margins and sales gains.
Zacks Investment Research • Jun 4, 2026

NVST Stock Explained for 2026 Growth Drivers and Risks
Envista targets margin gains via its Business System while boosting R&D and buybacks, with a $24 6-12 month target vs $22.94.
Zacks Investment Research • Jun 3, 2026

Here's Why Envista (NVST) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Jun 2, 2026

Why Envista (NVST) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • May 15, 2026

Envista Q1 Earnings Call Highlights
Envista NYSE: NVST reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and commercial capabilities.
MarketBeat • May 13, 2026

Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
With consumer sentiment sitting at 53.3 in March 2026, deep in pessimistic territory, retail investors are hunting for defensive names that can grow even as households tighten budgets.
24/7 Wall Street • May 13, 2026

Envista (NVST) International Revenue Performance Explored
Explore Envista's (NVST) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Zacks Investment Research • May 11, 2026

Why Envista (NVST) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • May 8, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Envista Holdings Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.